Today's Hours: 8:00am - 6:00pm

Search

Did You Mean:

Search Results

  • Book
    Seung-Hoon Lee, editor.
    Summary: This book presents state of the art knowledge on stroke management in a unique organizational style. Ischemic stroke is extensively covered, with inclusion of overviews that dynamically describe all relevant diagnostic and therapeutic processes in a time sequence mirroring real practice. The individual components of management and key issues are fully discussed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. In addition, the book considers the various causes of stroke and provides detailed guidance on means of secondary prevention. The recent demonstration of the substantial benefit of intra-arterial thrombectomy using stentrievers in patients with acute ischemic stroke represents a great moment in the history of stroke management. As we embark on a new era, there is an urgent need to review and evaluate current modalities for stroke diagnosis and treatment. In tackling this task, this book will be invaluable for physicians, angiographic interventionists, surgeons, and students seeking to acquire up-to-date knowledge on stroke.

    Contents:
    1. Initial assessment of patients with stroke-like symptoms
    2. Diagnosis and treatment of ischemic stroke: acute stage
    3. Diagnosis and treatment of hemorrhagic stroke: acute stage
    4. Certain, but relatively frequent causes of ischemic stroke
    5. Secondary prevention of stroke
    6. Clinical practice guidelines.
    Digital Access Springer 2017
  • Article
    Karabanow O.
    J Int Med Res. 1977;5 Suppl 5:42-8.
    A double-blind between-patient study is described which was aimed at assessing the efficacy and tolerability of clomipramine (Anafranil, Geigy Pharmacetuicals) in clinically depressed patients with obsessive-compulsive and phobic psychopathological traits. Twenty patients of either sex aged between 18 and 65 years were randomly allocated to treatment with clomipramine (50 mg twice daily) or to treatment with an identical placebo. Patients were assessed at the commencement of the study and at two-weekly intervals over the six-week duration of the trial. By the methods of assessment used, clomipramine proved to be highly statistically significantly superior to placebo.
    Digital Access Access Options